These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38132389)

  • 1. Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
    Tankel J; Spicer J; Chu Q; Fiset PO; Kidane B; Leighl NB; Joubert P; Maziak D; Palma D; McGuire A; Melosky B; Snow S; Bahig H; Blais N
    Curr Oncol; 2023 Dec; 30(12):10363-10384. PubMed ID: 38132389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study.
    Isla D; Felip E; Garrido P; Insa A; Majem M; Remon J; Trigo JM; de Castro J
    Clin Transl Oncol; 2023 Jan; 25(1):283-291. PubMed ID: 36168085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
    Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023.
    Al-Mansor E; Mahoney M; Chenard-Poirier M; Ramjeesingh R; Nair V; Kennedy E; Locke G; Welch S; Berry S; Couture F; Elimova E; Pollett A; Mahmud A; Wilson B; Armstrong D; Falkson C; Asmis T; Vickers M; Goodwin R
    Curr Oncol; 2023 Sep; 30(9):8172-8185. PubMed ID: 37754508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
    Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
    J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.
    Zemanova M; Jakopovic M; Stanic K; Łazar-Poniatowska M; Vrankar M; Rusu P; Ciuleanu T; Radosavljevic D; Bogos K; Nawrocki S
    Radiol Oncol; 2020 Oct; 54(4):447-454. PubMed ID: 33048837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
    Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
    Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.
    Nguyen TK; Senan S; Bradley JD; Franks K; Giuliani M; Guckenberger M; Landis M; Loo BW; Louie AV; Onishi H; Schmidt H; Timmerman R; Videtic GMM; Palma DA
    Pract Radiat Oncol; 2018; 8(2):e71-e78. PubMed ID: 29291965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung Cancer.
    Kim SS; Cooke DT; Kidane B; Tapias LF; Lazar JF; Awori Hayanga JW; Patel JD; Neal JW; Abazeed ME; Willers H; Shrager JB
    Ann Thorac Surg; 2025 Jan; 119(1):16-33. PubMed ID: 39424119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations.
    Sun A; Abdulkarim B; Blais N; Greenland J; Louie AV; Melosky B; Schellenberg D; Snow S; Liu G
    Lung Cancer; 2023 May; 179():107166. PubMed ID: 36944282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium.
    Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR
    Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report.
    Hardenberg MC; Patel B; Matthews C; Califano R; Garcia Campelo R; Grohe C; Hong MH; Liu G; Lu S; de Marinis F; Pérol M; Soo RA; Stiles BM; Tiseo M; Tsuboi M
    ESMO Open; 2022 Oct; 7(5):100572. PubMed ID: 36108559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delphi Expert Consensus of the German Society for Thoracic Surgery on Segmentectomy for Non-small Cell Lung Cancer].
    Koryllos A; Veit S; Schega O; Leschber G; Ludwig C
    Zentralbl Chir; 2024 Feb; 149(1):123-127. PubMed ID: 37402390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality indicators for non-small cell lung cancer operations with use of a modified Delphi consensus process.
    Darling G; Malthaner R; Dickie J; McKnight L; Nhan C; Hunter A; McLeod RS;
    Ann Thorac Surg; 2014 Jul; 98(1):183-90. PubMed ID: 24775804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document.
    Pennathur A; Brunelli A; Criner GJ; Keshavarz H; Mazzone P; Walsh G; Luketich J; Liptay M; Wafford QE; Murthy S; Marshall MB; Tong B; Lanuti M; Wolf A; Pettiford B; Loo BW; Merritt RE; Rocco G; Schuchert M; Varghese TK; Swanson SJ;
    J Thorac Cardiovasc Surg; 2021 Dec; 162(6):1605-1618.e6. PubMed ID: 34716030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
    Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
    Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical perspective in neoadjuvant chemoimmunotherapy for stage II-III non-small cell lung cancer.
    Hong T; Sun T; Zhang M; Liu X; Yuan Y; Dolo PR; Chen B; Zhang H
    Thorac Cancer; 2021 Oct; 12(20):2796-2802. PubMed ID: 34463034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    Moghanaki D; Simone CB; Rimner A; Karas TZ; Donington J; Shirvani SM; Daly M; Videtic GM; Movsas B;
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):429-431. PubMed ID: 29245205
    [No Abstract]   [Full Text] [Related]  

  • 20. A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles.
    Gandhi S; Brackstone M; Hong NJL; Grenier D; Donovan E; Lu FI; Skarpathiotakis M; Lee J; Boileau JF; Perera F; Simmons C; Joy AA; Tran WT;
    Breast Cancer Res Treat; 2022 May; 193(1):1-20. PubMed ID: 35224713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.